Clearmind Medicine, Inc. (CMND)
4.53
-0.09
(-1.95%)
USD |
NASDAQ |
Nov 13, 16:00
4.465
-0.06
(-1.43%)
After-Hours: 19:59
Clearmind Medicine Price : 4.53 for Nov. 13, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 13, 2026 | 4.52 | 4.785 | 4.35 | 4.53 | 3428.00 |
| Nov 12, 2026 | 4.775 | 4.811 | 4.62 | 4.62 | 10526.00 |
| Nov 11, 2026 | 5.415 | 5.579 | 4.93 | 4.95 | 5738.00 |
| Nov 10, 2026 | 5.76 | 5.76 | 5.09 | 5.09 | 6946.00 |
| Nov 09, 2026 | 5.70 | 5.77 | 5.400 | 5.50 | 5258.00 |
| Nov 06, 2026 | 5.71 | 5.71 | 5.400 | 5.584 | 13424.00 |
| Nov 05, 2026 | 5.925 | 5.99 | 5.60 | 5.85 | 3625.00 |
| Nov 04, 2026 | 5.992 | 6.107 | 5.81 | 5.92 | 3529.00 |
| Nov 03, 2026 | 5.81 | 6.10 | 5.43 | 5.92 | 4700.00 |
| Nov 02, 2026 | 6.02 | 6.14 | 6.01 | 6.14 | 1915.00 |
| Oct 30, 2026 | 5.83 | 6.499 | 5.80 | 6.219 | 10472.00 |
| Oct 29, 2026 | 6.15 | 6.166 | 5.85 | 5.85 | 4364.00 |
| Oct 28, 2026 | 5.977 | 6.15 | 5.977 | 6.06 | 5026.00 |
| Oct 27, 2026 | 6.095 | 6.095 | 5.948 | 5.967 | 5504.00 |
| Oct 26, 2026 | 5.92 | 6.20 | 5.860 | 6.121 | 16360.00 |
| Oct 23, 2026 | 6.255 | 6.255 | 5.87 | 5.87 | 8418.00 |
| Oct 22, 2026 | 6.01 | 6.095 | 6.00 | 6.00 | 5301.00 |
| Oct 21, 2026 | 6.252 | 6.252 | 5.92 | 5.94 | 5328.00 |
| Oct 20, 2026 | 5.971 | 6.19 | 5.91 | 6.12 | 6998.00 |
| Oct 19, 2026 | 6.164 | 6.362 | 5.91 | 6.00 | 8309.00 |
| Oct 16, 2026 | 6.33 | 6.47 | 6.260 | 6.260 | 4137.00 |
| Oct 15, 2026 | 6.24 | 6.79 | 6.24 | 6.42 | 5684.00 |
| Oct 14, 2026 | 6.36 | 6.47 | 6.20 | 6.289 | 10814.00 |
| Oct 13, 2026 | 6.50 | 6.73 | 6.23 | 6.23 | 11006.00 |
| Oct 12, 2026 | 6.52 | 6.80 | 6.481 | 6.54 | 16204.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| NervGen Pharma Corp. | 1.88 |
| Milestone Pharmaceuticals, Inc. | 0.52 |
| Appili Therapeutics, Inc. | 0.002 |
| Lexaria Bioscience Corp. | 4.44 |
| Target Group, Inc. (Canada) | 0.0009 |
Price Related Metrics
| Price to Book Value | 0.0938 |
| Earnings Yield | -15.57K% |
| Market Cap | 1.215M |